MedPath

Psilocybin as a tool for enhancing cognitive flexibility”

Conditions
psilocybin, divergent thinking, neurotransmission
Registration Number
NL-OMON25919
Lead Sponsor
niversity Maastricht (UM)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

•Previous experience with a psychedelic drug, but not within the past 6 months.

•Age between 18 and 40 years

Exclusion Criteria

•History of drug addiction (determined by the medical questionnaire, drug questionnaire and medical examination)

•Previous experience of serious side effects to psychedelic drugs (anxiety or panic attacks)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To use psilocybin as a research tool in order to enhance divergent thinking, and facilitate relative goal-directed versus habitual behaviour during and after drug intoxication, and to assess whether psilocybin will deter a stress induced shift from goal directed to habitual behaviour.
Secondary Outcome Measures
NameTimeMethod
To assess cortical-subcortical functional connectivity alterations, as well as the relationship between metabolic activity and behavioural outcomes. Furthermore, subjective experience and drug concentration levels will be assessed in relation to the aforementioned variables.
© Copyright 2025. All Rights Reserved by MedPath